Mankind Pharma Limited announced that the Company has received an Order from Office of Commissioner of Central Tax, Central Excise and Service tax, Secunderabad GST Commissionerate GST Bhawan, Hyderabad ("Department") dated April 25, 2024 received on April 26, 2024 imposing a penalty of INR 2,452,328/- under applicable provisions of the CGST Act, 2017. The Company is examining the aforesaid Order received from the Department and shall take appropriate steps, including filing of an appeal. There is no material impact on financials, operations or other activities of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,140 INR | +2.18% | +3.73% | +7.93% |
05-30 | Advent International Receives 6-7 Bids for Bharat Serums | CI |
05-16 | Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.93% | 10.27B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- MANKIND Stock
- News Mankind Pharma Limited
- Mankind Pharma Limited Receives Order from Office of Commissioner of Central Tax, Central Excise and Service Tax, Secunderabad GST Commissionerate GST Bhawan, Hyderabad